tiprankstipranks
Trending News
More News >
Advertisement
Advertisement
Obefazimod: Favorable Risk‑Reward on Strong UC Efficacy, Emerging Crohn’s Opportunity, and Undervalued Commercial Upside
PremiumRatingsObefazimod: Favorable Risk‑Reward on Strong UC Efficacy, Emerging Crohn’s Opportunity, and Undervalued Commercial Upside
6d ago
Abivax presents preclinical data for obefazimod
Premium
The Fly
Abivax presents preclinical data for obefazimod
7d ago
Abivax management to meet with Piper Sandler
Premium
The Fly
Abivax management to meet with Piper Sandler
10d ago
Abivax SA: Strengthened Outlook for Obefazimod in IBD Drives Higher Target Price and Buy Rating
PremiumRatingsAbivax SA: Strengthened Outlook for Obefazimod in IBD Drives Higher Target Price and Buy Rating
2M ago
– Abivax SA American Depositary Shares call volume above normal and directionally bullish
Premium
The Fly
– Abivax SA American Depositary Shares call volume above normal and directionally bullish
2M ago
Abivax rumored to attract interest from Eli Lilly, La Tribune says
Premium
The Fly
Abivax rumored to attract interest from Eli Lilly, La Tribune says
2M ago
Abivax price target raised to $175 from $150 at Guggenheim
PremiumThe FlyAbivax price target raised to $175 from $150 at Guggenheim
2M ago
Abivax price target raised to $142 from $112 at Piper Sandler
Premium
The Fly
Abivax price target raised to $142 from $112 at Piper Sandler
3M ago
Abivax price target raised to $131 from $114 at Citizens
Premium
The Fly
Abivax price target raised to $131 from $114 at Citizens
3M ago

Trending

Name
Price
Price Change
S&P 500
Dow Jones
Nasdaq 100